🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher

Published 04/03/2024, 19:34
Updated 04/03/2024, 20:40
© Reuters.  Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher
US500
-
ZION
-
GC
-
HG
-
SI
-
CL
-
IXIC
-
SMCI
-
CRDF
-
DECK
-
RENX
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday.

The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell, dropping, 0.01% to 5,137.05.

Check This Out: Top 4 Tech Stocks That May Implode This Month

Leading and Lagging Sectors

Utilities shares rose by 0.9% on Monday.

In trading on Monday, communication services shares fell by 1.6%.

Top Headline

Super Micro Computer, Inc. (NASDAQ: SMCI) will join the S&P 500 Index, effective March 18, S&P Dow Jones Indices, a division of S&P Global, said in a release. Deckers Outdoor Corporation (NASDAQ: DECK) will replace Zions Bancorporation (NASDAQ: ZION) in the S&P 500.

Equities Trading UP

Cardiff Oncology, Inc. (NASDAQ: CRDF) shares shot up 16% to $3.3862 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.

Shares of Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) got a boost, surging 23% to $3.4550 after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.

Renalytix Plc (NASDAQ: RNLX) shares were also up, gaining 27% to $1.3250 after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.

Equities Trading DOWN

BioVie Inc. (NASDAQ: BIVI) shares dropped 43% to $1.0850 after the company reported pricing of public offering.

Shares of BioCardia, Inc. (NASDAQ: BCDA) were down 21% to $0.4599 after reporting interim results from Phase III CardiAMP cell therapy heart failure trial.

JOANN Inc. (NASDAQ: JOAN) was down, falling 42% to $0.2937 following a Bloomberg report stating the company is contemplating a bankruptcy filing to restructure its debt and regain financial stability.

Also Check This Out: 'I Think You've Got An Interesting Stock Here': Cramer On This Advertising Company

Commodities

In commodity news, oil traded down 1.5% to $78.72 while gold traded up 1.5% at $2,126.00.

Silver traded rose 2.7% to $23.99 on Monday while copper fell 0.2% to $3.8530.

Euro zone

European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.03%, London’s FTSE 100 fell 0.55% while Spain’s IBEX 35 Index rose 0.05% The German DAX declined 0.11% French CAC 40 rose 0.28% while Italy’s FTSE MIB Index fell 0.07%.

The number of people registering as jobless in Spain declined by 0.3% to 2.76 million in February.

Asia Pacific Markets

Asian markets closed higher on Monday, with Japan’s Nikkei 225 gaining 0.50%, Hong Kong’s Hang Seng Index climbing 0.04%, China’s Shanghai Composite Index gaining 0.41% and India’s S&P BSE Sensex gaining 0.2%.

Singapore’s manufacturing PMI slipped to 50.6 in February from 50.7 in the prior month.

Economics

No economic report of significance is due for Monday.

Now Read This: How To Earn $500 A Month From Nordstrom Stock Ahead Of Q4 Earnings Report

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.